NATALIA
CHUECA PORCUNA
Investigadora en el periodo 2007-2008
Hospital Universitario Reina Sofia
Córdoba, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Reina Sofia (18)
2024
-
Molecular and phylogenetic characterization of the monkeypox outbreak in the South of Spain
Health Science Reports, Vol. 7, Núm. 3
2023
-
Detection of High Level of Co-Infection and the Emergence of Novel SARS CoV-2 Delta-Omicron and Omicron-Omicron Recombinants in the Epidemiological Surveillance of Andalusia
International journal of molecular sciences, Vol. 24, Núm. 3
2022
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
-
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort
HIV Medicine, Vol. 23, Núm. 8, pp. 825-836
2021
-
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy
Journal of Hepatology, Vol. 74, Núm. 4, pp. 801-810
2020
-
A multi-omics approach reveals new signatures in obese allergic asthmatic children
Biomedicines, Vol. 8, Núm. 9
-
Sample pooling for SARS-CoV-2 RT-PCR screening
Clinical Microbiology and Infection, Vol. 26, Núm. 12, pp. 1687.e1-1687.e5
2019
-
Autism spectrum disorder (ASD) with and without mental regression is associated with changes in the fecal microbiota
Nutrients, Vol. 11, Núm. 2
-
Cross-country migration linked to people who inject drugs challenges the long-term impact of national HCV elimination programmes
Journal of Hepatology
-
High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world
Journal of Hepatology, Vol. 71, Núm. 5, pp. 876-888
-
Increasing importance of european lineages in seeding the hepatitis C virus subtype 1a epidemic in Spain
Eurosurveillance, Vol. 24, Núm. 9
-
Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort
PLoS ONE, Vol. 14, Núm. 8
2018
-
Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
Medicine (United States), Vol. 97, Núm. 38
-
Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis
PLoS ONE, Vol. 13, Núm. 7
2017
2016
-
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013
Journal of Infection, Vol. 72, Núm. 5, pp. 587-596
-
MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression
PLoS ONE, Vol. 11, Núm. 5
2011
-
La respuesta virológica al tratamiento con adefovir dipivoxil predice el desarrollo de resistencias a largo plazo en pacientes con hepatitis crónica B HBeAg negativo previamente no tratados
Gastroenterologia y Hepatologia, Vol. 34, Núm. 2, pp. 69-74